T lymphopenia in multiple sclerosis patients treated with ofatumumab: Even with consideration for CD3 + CD20+ cells.
Saved in:
| Title: | T lymphopenia in multiple sclerosis patients treated with ofatumumab: Even with consideration for CD3 + CD20+ cells. |
|---|---|
| Authors: | Tanaka M; Kyoto MS Center, Kyoto Min-Iren Chuo Hospital, Kyoto, Japan.; Department of Neurology, Kaikokai Josai Hospital, Nagoya, Japan., Kinoshita M; Department of Neurology, Utano National Hospital, Kyoto, Japan., Tanaka K; Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, Fukushima, Japan. |
| Source: | Multiple sclerosis journal - experimental, translational and clinical [Mult Scler J Exp Transl Clin] 2026 Jan 02; Vol. 12 (1), pp. 20552173251409954. Date of Electronic Publication: 2026 Jan 02 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Ltd Country of Publication: United States NLM ID: 101668877 Publication Model: eCollection Cited Medium: Print ISSN: 2055-2173 (Print) Linking ISSN: 20552173 NLM ISO Abbreviation: Mult Scler J Exp Transl Clin Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
